Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine<sup>®</sup>) with Latanoprost Eye Drops (Xalatan<sup>®</sup>) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

J Clin Med · 2025 · PMC12733906 · PMID 41464831

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This finding was not confirmed for the second day; the result only just did not reach statistical significance, but the values in both cohorts were very close to one another, with a difference of −0.2 mmHg for latanoprost versus PF tafluprost.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine&lt;sup&gt;®&lt;/sup&gt;) with Latanoprost Eye Drops (Xalatan&lt;sup&gt;®&lt;/sup&gt;) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

The sentences

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine<sup>®</sup>) with Latanoprost Eye Drops (Xalatan<sup>®</sup>) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.